REGEN
Get REGENGet Now
LibraryToolsNotesBlogFAQ

SLU-PP-915 Dosage and Protocols

SLU-PP-915 dosage protocols reported in published research, plus reconstitution and storage.

RE
Compiled from published research · Last updated 2026-08-18T00:00:00.000Z

Research Protocol Range

Research-vendor products are commonly dosed at 10-25mg orally once daily. Since no human trial exists, this range reflects informal research-community convention extrapolated from mouse dosing, not validated human guidance.

Reported protocol doses

Standard dose10–25 mg
Frequency1x daily
Routesoral

Doses shown are those reported in published research, not a recommendation.

References

  1. SLU-PP-915 orally-active ERR agonist exercise study · Billon C, et al. · 2025
All SLU-PP-915 sections

SLU-PP-332

longevity & healthspanDgrade

A pan-ERR agonist nicknamed the 'exercise pill' — reduced fat mass and raised fatty-acid oxidation in obese mice, with zero human trials as of 2026.

Thymosin Alpha-1

longevity & healthspanAgrade

A 28-amino-acid thymic peptide approved in 35+ countries as Zadaxin for immune support — but never FDA-approved in the United States.

Oxytocin

longevity & healthspanBgrade

A naturally occurring nonapeptide — FDA-approved as Pitocin for labor, and separately studied off-label (intranasal) for social bonding and stress research.

Put the whole protocol
in one place.

Download nowGet Now